NCT06742086View on ClinicalTrials.gov

A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

October 8, 2025

Study Completion Date

October 8, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

Venetoclax

Oral Tablet

Trial Locations (2)

60030

Acpru /Id# 272979, Grayslake

78744

PPD Phase I Clinic /ID# 275754, Austin

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY